The Chinese herbal formula granules industry trends have seen significant momentum over the past 18 months, driven by digital integration, regulatory reforms, and shifting consumer demand. Notably, participations between traditional herbal manufacturers and tech firms have accelerated, with companies like Tong Ren Tang partnering with AI-driven health platforms to enhance personalized herbal prescriptions. Meanwhile, mergers & acquisitions activity has intensified, exemplified by Jiangxi Nanguang Pharmaceutical’s acquisition of a regional granule producer to consolidate supply chain efficiency and expand into Southeast Asia. On the innovation front, advancements in smart packaging with QR code traceability and instant-soluble granule formulations have emerged, addressing modern consumers’ demand for transparency and convenience. Regulatory shifts, including China’s 2024 revision of Good Manufacturing Practices (GMP) for herbal products, have raised quality benchmarks, prompting firms to invest in compliance upgrades. Enterprise-level demand for herbal granules in preventive healthcare programs has also surged, particularly in wellness-focused sectors, while startups securing Series A funding are prioritizing sustainable, climate-resilient cultivation methods to future-proof supply chains.
